Abstract:Background: Episodic ataxias are rare neurological disorders characterized by recurring episodes of imbalance and coordination difficulties. Obtaining definitive molecular diagnoses poses challenges, as clinical presentation is highly heterogeneous, and literature on the underlying genetics is limited. While the advent of high-throughput sequencing technologies has significantly contributed to Mendelian disorders genetics, interpretation of variants of uncertain significance and other limitations inherent to individual methods still leaves many patients undiagnosed. This study aimed to investigate the utility of multi-omics for the identification and validation of molecular candidates in a cohort of complex cases of ataxia with episodic presentation. Methods: Eight patients lacking molecular diagnosis despite extensive clinical examination were recruited following standard genetic testing. Whole genome and RNA sequencing were performed on samples isolated from peripheral blood mononuclear cells. Integration of expression and splicing data facilitated genomic variants prioritization. Subsequently, long-read sequencing played a crucial role in the validation of those candidate variants. Results: Whole genome sequencing uncovered pathogenic variants in four genes ( SPG7 , ATXN2 , ELOVL4 , PMPCB ). A missense and a nonsense variant, both previously reported as likely pathogenic, configured in trans in individual #1 ( SPG7 : c.2228T>C/p.I743T, c.1861C>T/p.Q621*). An ATXN2 microsatellite expansion (CAG 32 ) in another late-onset case. In two separate individuals, intronic variants near splice sites ( ELOVL4 : c.541 + 5G>A; PMPCB : c.1154 + 5G>C) were predicted to induce loss-of-function splicing, but had never been reported as disease-causing. Long-read sequencing confirmed the compound heterozygous variants configuration, repeat expansion length, as well as splicing landscape for those pathogenic variants. A potential genetic modifier of the ATXN2 expansion was discovered in ZFYVE26 (c.3022C>T/p.R1008*). Conclusion: Despite failure to identify pathogenic variants through clinical genetic testing, the multi-omics approach enabled the molecular diagnosis in 50% of patients, also giving valuable insights for variant prioritization in remaining cases. The findings demonstrate the value of long-read sequencing for the validation of candidate variants in various scenarios. Our study demonstrates the effectiveness of leveraging complementary omics technologies to unravel the underlying genetics in patients with unresolved rare diseases such as ataxia. Molecular diagnoses not only hold significant promise in improving patient care management, but also alleviates the burden of diagnostic odysseys, more broadly enhancing quality of life.

Clinical and Genetic Characterization of a Cohort of Brazilian Patients With Congenital Ataxia

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

Spinocerebellar Ataxia in Brazil: A Comprehensive Genotype – Phenotype Analysis

Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS

Cerebellar Ataxia in Children: A Clinical and MRI Approach to the Differential Diagnosis

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

[Rare forms of autosomal recessive spinocerebellar ataxia associated with mutations in the ANO10 (ATX-ANO10) and SYNE1 (ATX-SYNE1) genes]

Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children

Genetic Causes of early onset Ataxia: Experience from the National Sheffield Paediatric Ataxia Centre.

Identifying Gene Mutations in Autosomal Recessive Cerebellar Ataxias and Extending the Mutational Spectrum in China

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Exome sequencing as a diagnostic tool for pediatric-onset ataxia

Tgm6 Identified As A Novel Causative Gene of Spinocerebellar Ataxias Using Exome Sequencing

Integration of multi-omics technologies for molecular diagnosis in ataxia patients

Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance

An atypical form of AOA2 with myoclonus associated with mutations in SETX and AFG3L2

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

The Phenotypic Spectrum of Spinocerebellar Ataxia Type 19 in a Series of Latin American Patients

Other autosomal recessive and childhood ataxias

Genetic Etiology of a Chinese Ataxia Cohort: Expanding the Mutational Spectrum of Hereditary Ataxias.